NIH-funded research Training grant

Training future experts in cancer-related viruses

Official title: Training in Tumor Virology

Funded at University of Pennsylvania · NIH-11089461 · Data updated 2026-11-12

This program is designed to help students learn about how certain viruses, like HIV and HPV, can lead to cancer, giving them hands-on experience and guidance from experts to improve cancer research and treatment, especially for patients with weakened immune systems.

Quick facts

Grant typeTraining grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startMay 15, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$461,022
NIH project number5T32CA288356-02
Project IDNIH-11089461 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are predoctoral and postdoctoral students interested in pursuing careers in biomedical research related to cancer and virology.

Less likely to help

Patients not involved in academic training or those not affected by virus-associated cancers may not receive direct benefits from this research.

What this research studies

This program focuses on training predoctoral and postdoctoral students in the field of tumor virology, which studies how certain viruses contribute to cancer development. The training involves hands-on experience and mentorship from leading experts in the field, covering various viruses such as HIV, HPV, and others linked to cancer. Participants will engage in research that explores the mechanisms by which these viruses influence cancer progression, particularly in immunocompromised patients. The program aims to enhance the skills and knowledge of emerging scientists to advance cancer research and treatment.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for virus-associated cancers.

How similar studies have gone: Previous training programs in tumor virology have shown success in developing skilled researchers who contribute significantly to the field.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Robertson, Erle S. — University of Pennsylvania
  • Study coordinator: Robertson, Erle S.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.